Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas. [electronic resource]
Producer: 20171205Description: 4631-4639 p. digitalISSN:- 1097-0142
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Brain Neoplasms -- drug therapy
- Everolimus -- therapeutic use
- Female
- Follow-Up Studies
- Gene Expression Regulation, Neoplastic -- drug effects
- Glioma -- drug therapy
- Humans
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Phosphoinositide-3 Kinase Inhibitors
- Prospective Studies
- Survival Rate
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.